Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Jushi Holdings (JUSH) is set to acquire the remaining 25 per cent interest in TGS Holdings Illinois
  • The company originally acquired 75 per cent of TGS at the end of January
  • With adult-use now legalized in the state, Illinois has seen over C$39.2 million in recreational cannabis sales
  • Shares in Jushi are currently trading at C$1.69, with a market cap of C$154.86 million

Jushi Holdings (JUSH) has entered an agreement to acquire the remaining 25 per cent stake in TGS Holdings Illinois.

On January 30, Jushi announced that it had, through its wholly owned subsidiary Jushi Inc., acquired a 75 per cent interest in TGS Illinois, which owns and operates two medical dispensaries in Sauget and Normal.

There are currently 55 medical dispensaries operating in Illinois, and each has the option to add a second retail location to act as an ‘adult-use’ outlet.

Jushi plans to exercise its right to add adult-use locations and has already received approval for its Sauget store.

“As the sole owner of two medical dispensaries with the opportunity to turn adult-use as well as expand to four locations, we believe in our investment into the Illinois market and the demand that exists in this state,” said Jushi CEO, Jim Cacioppo.

“With our entry into Illinois, we continue Jushi’s mission to expand across limited license states and municipalities coast-to-coast.”

With adult-use approved at the beginning of this year, Illinois has seen over C$39.2 million in sales of recreational cannabis in January alone, equivalent to C$3.07 in sales per resident.

The Jushi-TGS agreement is all but set in stone, with the exception of regulatory approval from the Illinois Department of Financial and Professional Regulation.

Shares in Jushi are currently trading at C$1.69, with a market cap of C$154.86 million.

More From The Market Herald

" The Market Herald’s Weekly Cannabis Report

Weekly Update – Top Cannabis News Stories

" BioHarvest Sciences welcomes Gavriel Lambert to the Board of Advisors

BioHarvest Sciences (BHSC) has appointed Gavriel Lambert to serve on its Board of Advisors.
Pure Extracts Technologies - CEO, Ben Nikolaevsky.

" Pure Extracts (CSE:PULL) signs supplier agreement with Shoppers Drug Mart

Pure Extracts (PULL) has signed a cannabis supplier agreement with Shoppers Drug Mart.

" Tilray (TSX:TLRY) expands medical cannabis products in the UK

Tilray Brands’ (TLRY) medical cannabis division, Tilray Medical, has expanded its medical cannabis offerings in the United Kingdom.